245 related articles for article (PubMed ID: 22435424)
21. [Extramedullary initial manifestations of acute myeloid leukemia (AML)].
Schmitt-Gräff A; Wickenhauser C; Kvasnicka HM; Dries V; Thiele J
Pathologe; 2002 Nov; 23(6):397-404. PubMed ID: 12436291
[TBL] [Abstract][Full Text] [Related]
22. Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates.
Kaiserling E; Horny HP; Geerts ML; Schmid U
Mod Pathol; 1994 Sep; 7(7):771-9. PubMed ID: 7824512
[TBL] [Abstract][Full Text] [Related]
23. Myelogenous leukemia cutis resembling stasis dermatitis.
Chang HY; Wong KM; Bosenberg M; McKee PH; Haynes HA
J Am Acad Dermatol; 2003 Jul; 49(1):128-9. PubMed ID: 12833025
[TBL] [Abstract][Full Text] [Related]
24. Pathologic sideroblastosis in myelodysplastic syndromes and acute nonlymphocytic leukemia.
Bernardeschi P; Bonechi I
Recenti Prog Med; 1991 Nov; 82(11):588-90. PubMed ID: 1763231
[TBL] [Abstract][Full Text] [Related]
25. Disappearing myelodysplastic syndrome-associated hemolytic anemia in leukemic transformation.
Tabata R; Tabata C; Omori K; Nagai T
Int Arch Allergy Immunol; 2010; 152(4):407-12. PubMed ID: 20197683
[TBL] [Abstract][Full Text] [Related]
26. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
Koh Y; Kim I; Bae JY; Song EY; Kim HK; Yoon SS; Lee DS; Park SS; Park MH; Park S; Kim BK
Jpn J Clin Oncol; 2010 Nov; 40(11):1037-45. PubMed ID: 20587614
[TBL] [Abstract][Full Text] [Related]
27. Myeloid sarcoma developing in pre-existing pyoderma gangrenosum.
Kristensen IB; Møller H; Kjaerskov MW; Yderstraede K; Møller MB; Bergmann OJ
Acta Derm Venereol; 2009; 89(2):175-7. PubMed ID: 19326005
[TBL] [Abstract][Full Text] [Related]
28. Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9 cases.
Vignon-Pennamen MD; Juillard C; Rybojad M; Wallach D; Daniel MT; Morel P; Verola O; Janin A
Arch Dermatol; 2006 Sep; 142(9):1170-6. PubMed ID: 16983004
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous alternariosis revealing acute myeloid leukaemia in an adult patient.
Ioannidou D; Maraki S; Krüger Krasagakis S; Stefanidou M; Krasagakis K; Alexandrakis M; Tosca A
Mycoses; 2004 Jun; 47(5-6):227-30. PubMed ID: 15189189
[TBL] [Abstract][Full Text] [Related]
30. A case of monocytic leukaemia cutis in a patient with myelodysplastic syndrome transforming to acute myeloid leukaemia.
Perez A; Kennedy C; Standen G; Oxley J
Clin Exp Dermatol; 2004 Sep; 29(5):497-8. PubMed ID: 15347335
[TBL] [Abstract][Full Text] [Related]
31. Aleukemic leukemia cutis preceding overt acute myeloid leukemia in myelodysplastic syndrome.
Rodríguez JN; Fernandez-Jurado A; Navarro A; Martino ML; Prados D
Am J Hematol; 1997 Jan; 54(1):91-2. PubMed ID: 8980276
[No Abstract] [Full Text] [Related]
32. Expression of JL1 is an effective adjunctive marker of leukemia cutis.
Park YS; Park SH; Park SJ; Kim Y; Jang KT; Ko YH; Lee MW; Huh JR; Park CS
Arch Pathol Lab Med; 2010 Jan; 134(1):95-102. PubMed ID: 20073611
[TBL] [Abstract][Full Text] [Related]
33. Leukemic cluster growth in culture is an independent risk factor for acute myeloid leukemia and short survival in patients with myelodysplastic syndrome.
Bernimoulin M; Stern M; Tichelli A; Jotterand M; Gratwohl A; Nissen C
Acta Haematol; 2008; 119(4):226-35. PubMed ID: 18566541
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow leukaemic transformation of myelodysplastic syndrome revealed by a cutaneous Langerhans cell infiltrate: partial response to azacitidine.
Osio A; Elfatoiki F; Raffoux E; Vignon-Pennamen MD; de Labarthe A; Cordoliani F; Petrella T; Bagot M; Janin A; Battistella M; Bouaziz JD
Eur J Dermatol; 2013; 23(5):710-1. PubMed ID: 24125873
[No Abstract] [Full Text] [Related]
35. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.
Orazi A; Cattoretti G; Heerema NA; Sozzi G; John K; Neiman RS
Mod Pathol; 1993 Sep; 6(5):521-5. PubMed ID: 8248107
[TBL] [Abstract][Full Text] [Related]
36. [Specific and nonspecific skin manifestations in leukemia].
Büchner SA
Praxis (Bern 1994); 2002 Jun; 91(24):1071-7. PubMed ID: 12109056
[TBL] [Abstract][Full Text] [Related]
37. Concurrent Sweet's syndrome and leukemia cutis in patients with myeloid disorders.
del Pozo J; Martínez W; Pazos JM; Yebra-Pimentel MT; García Silva J; Fonseca E
Int J Dermatol; 2005 Aug; 44(8):677-80. PubMed ID: 16101872
[TBL] [Abstract][Full Text] [Related]
38. [Cutaneous symptoms revealing acute myeloid leukemia].
Ben Dhaou Hmaidi B; Boussema F; Baili L; Ketari S; Aydi Z; Cherif O; Rokbani L
Tunis Med; 2011 Dec; 89(12):946-7. PubMed ID: 22198880
[No Abstract] [Full Text] [Related]
39. [Choroid infiltration in myelodysplastic syndrome].
Madjlessi F; Dann K; Althaus C; Sundmacher R; Meckenstock G
Klin Monbl Augenheilkd; 1998 Jul; 213(1):51-4. PubMed ID: 9743940
[TBL] [Abstract][Full Text] [Related]
40. CD34/CD117 positivity in assessment of prognosis in children with myelodysplastic syndrome.
Tavil B; Cetin M; Tuncer M
Leuk Res; 2006 Feb; 30(2):222-4. PubMed ID: 16098587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
